Press release
Gene-to-Patient Market Expected to Reach $341.4 Billion by 2031 with a Robust 12.5% CAGR Driven by Advancements in Genetic Therapies
Gene-to-Patient Market
According to the latest research by InsightAce Analytic, the Gene-to-Patient Market is valued at US$ 134.6 Bn in 2023, and it is expected to reach US$ 341.4 Bn by 2031, with a CAGR of 12.5% during the forecast period of 2024-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2905
The "gene-to-patient" model refers to the process by which personalized genetic treatments are developed and delivered to patients, enhancing the precision and effectiveness of medical interventions by tailoring therapies to individual needs. This sector is experiencing rapid global growth, driven by the increasing prevalence of chronic diseases, expanded research and development initiatives, and the broader adoption of gene therapy. Additionally, numerous organizations worldwide are collaborating to explore more effective applications of gene-to-patient therapies. However, the industry faces significant challenges, including regulatory obstacles related to the approval and implementation of gene-to-patient treatments. The market's growth in developing countries is also constrained by concerns over the affordability and accessibility of healthcare. Despite these challenges, the gene-to-patient sector presents substantial growth opportunities as it adapts to evolving regulations and develops innovative solutions. These factors are anticipated to fuel the expansion of the gene-to-patient market in the coming years.
List of Prominent Players in the Gene-to-Patient Market:
• Illumina
• Thermo Fisher Scientific
• Roche Diagnostics
• Qiagen
• BioRad Laboratories
• Abbott Laboratories
• PerkinElmer
• Invitae
• Myriad Genetics
• Merck
• Guardant Health
• Foundation Medicine
• Genomic Health
• Agilent Technologies
• Laboratory Corporation of America (LabCorp)
• Exact Sciences
• Genscript Biotech Corporation
• CRISPR Therapeutics AG
• Editas Medicine
• Intellia Therapeutics Inc.
• Beam Therapeutics Inc.
• Caribou Biosciences Inc.
• Lonza Group Ltd.
• Other Market Players
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04
Market Dynamics:
Drivers:
The demand for gene therapies is experiencing significant growth, driven by the rising prevalence of genetic disorders and the increasing need for effective treatment options. Additionally, the growing trend toward personalized medicine is contributing to the market's expansion, as both patients and healthcare providers seek individualized treatment strategies based on genetic profiles. Advances in genetic engineering and biotechnology are enhancing the effectiveness of gene-to-patient therapies, enabling more precise identification of genetic defects and facilitating new breakthroughs in the treatment of complex genetic conditions. These innovations are fostering substantial growth within the sector.
Challenges:
A key challenge facing the gene-to-patient market is the general lack of public awareness regarding gene therapy, which impacts patient acceptance and limits broader adoption. Moreover, the high cost associated with gene therapy treatments remains a significant barrier to accessibility for many individuals. The market is also hindered by diverse and often stringent regulatory requirements across different regions, complicating the approval process and delaying market entry.
Regional Trends:
North America is expected to hold a dominant share of the gene-to-patient market in terms of revenue. The region's robust support for gene therapies, coupled with significant investment in biotechnology and gene therapy innovations, is driving rapid growth. The favorable regulatory environment and public funding further support clinical trials and the development of new products. In Europe, the gene-to-patient market is also experiencing considerable growth, fueled by factors such as urbanization, enhanced healthcare infrastructure, and increased discretionary income, all of which are contributing to the expansion of healthcare and the gene-to-patient market in the region.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2905
Recent Developments:
• In March 2024, Merck, a frontrunner in the scientific and technological industries, introduced the world to the first comprehensive, laboratory-validated genetic stability test. Accelerating biosafety assessment and the transition into commercial production, the Aptegra CHO genetic stability assay utilizes whole genome sequencing and bioinformatics.
Segmentation of Gene-to-Patient Market-
By Type-
• Gene Therapy
• Gene Editing
• Gene Silencing
By Application-
• Cancer Treatment
• Genetic Disorders
• Cardiovascular Diseases
• Rare Diseases
• Infectious Diseases
By End-user-
• Hospitals
• Research Institutes
• Biopharmaceutical Companies
• Diagnostic Laboratories
By Technology-
• CRISPR
• Viral Vector Technology
• Non-Viral Delivery Technology
• Antisense Oligonucleotide Technology
By Distribution Channel-
• Direct Sales
• Online Sales
• Third-party Distributors
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
Read Overview Report- https://www.insightaceanalytic.com/report/gene-to-patient-market/2905
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gene-to-Patient Market Expected to Reach $341.4 Billion by 2031 with a Robust 12.5% CAGR Driven by Advancements in Genetic Therapies here
News-ID: 3994014 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
4PL Logistics Market Revenue Report with Forecast to 2034
"4PL Logistics Market" in terms of revenue was estimated to be worth $59.6 Billion in 2024 and is poised to reach $133.3 Billion by 2034, growing at a CAGR of 8.5% from 2025 to 2034 according to a new report by InsightAce Analytic.
Get Free Sample Report @
https://www.insightaceanalytic.com/request-sample/1609
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global 4PL Logistics Market are:
• Rapid growth of automotive the…
Heavy-Duty Autonomous Vehicle Market Exclusive Trends Analysis with Forecast to …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Heavy-Duty Autonomous Vehicle Market- (By Application (Logistics, Public Transportation, Construction and Mining, Others), By Propulsion Type (Internal Combustion Engine Vehicles, Electric Vehicles), By Vehicle Type (Heavy Trucks, Heavy Buses, Roboshuttles), By Level of Autonomy (Fully Autonomous Vehicles, Semi-Autonomous Vehicles), By Sensor Type (LiDAR, RADAR, Camera, Others)) Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According…
E-Commerce Logistics Market Exclusive Report with Detailed Study Analysis
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global E-Commerce Logistics Market Size, Share & Trends Analysis Report By Service Type (Transportation And Warehousing) And Operational Area (International And Domestic)- Market Outlook And Industry Analysis 2034"
The global e-commerce logistics market is estimated to reach over USD 5340.2 billion by 2034, exhibiting a CAGR of 26.4% during the forecast period.
Request For Free Sample Pages:…
E-bikes Market Exclusive Report on the Latest Revenue and Future Scope
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global E-bikes Market Size, Share & Trends Analysis Report By Class (Class-I, Class-II, Class-III), Speed (Up to 25km/h, 25-45 km/h), Battery Type (Lithium-ion, Lithium-ion Polymer, Lead Acid), Mode (Pedal Assist, Throttle), Component (batteries, electric motors, frames with forks, wheels, crank gears, brake systems and motor controllers) , Motor Type (hub and mid), Usage (mountain, trekking, city/urban,…
More Releases for Gene
DNA and Gene Cloning Services Market Expands with Growing Focus on Complex Gene …
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global DNA and Gene Cloning Services Market by Type of Service Offered (Custom Cloning, Sub-cloning, Gene Synthesis, and Others), Type of Gene (Complex Gene, Standard Gene, and Others), End-User Industry (Pharmaceutical, Academic and R&D, and Biotechnology Companies, and Others)- Market Outlook and Industry Analysis 2034"
The DNA and Gene Cloning Services Market Size is valued…
Evolving Market Trends In The CRISPR Gene Editing Industry: Innovative Gene Ther …
The CRISPR Gene Editing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected CRISPR Gene Editing Market Size During the Forecast Period?
The CRISPR gene editing market has grown exponentially in recent years. It will grow from $2.26 billion in 2024 to $2.88…
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy …
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by…
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with…
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks.
The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,…
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies.
In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal…
